CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Planned sale Director sold 10,960 shares at $12.52 ($137,219)
- 4 Open-market sale EVP and General Counsel sold 76 shares at $8.22 ($625)
- 4 Grant or award EVP & Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Planned sale EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)
- 4 Planned sale EVP and General Counsel sold 3,750 shares at an average $8.62 ($32,332)
- 4 Other disposition Director disposed of 1,196,540 shares (other)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 12,190 shares at $7.80 ($95,032)
- 4 Grant or award EVP and Chief Medical Officer acquired 75,000 shares (grant or award)
- 4 Other disposition Chief Executive Officer disposed of 53,118 shares (other)
- 4 Open-market sale Director sold 4,000 shares at $10.95 ($43,789)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
Page 5 of 25 · 491 filings